Provider profile
Aragen.
Biologics CDMOs
Aragen, a CRDMO that also serves small-molecule programmes, describes biologics cell line development (CHO) in Morgan Hill, California and upstream, downstream and analytical development and cGMP clinical drug substance manufacturing of monoclonal antibodies in single-use bioreactors at Jigani, Bengaluru, India. Biologics drug product manufacturing is not documented. Its global headquarters is in Hyderabad, India.
- Website
- aragen.com (opens in a new tab)
- Sources reviewed
- November 4, 2026 · Source pages re-checked within 4 months
- First published
- November 3, 2026
This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.
Services and capabilities
Services and capabilities
- Analytical development and QC testing1
- Cell line development1,2Cell line development performed in Morgan Hill, California (Aragen Bioscience campus)
- Formulation development4Listed as formulation screening within biologics process research and development
- GMP drug substance manufacturing3Clinical drug substance; GMP capacity of 2.50 KL in Jigani, Bengaluru, commissioned in the third quarter of fiscal 2026
- Process development3
- Stability studies4Listed within biologics process research and development
- Technology transfer5Stated for biosimilars
Development experience
Development experience
Modality
- Monoclonal antibodies5mAb process development and manufacturing stated for the Bengaluru facility
Locations
Locations
- Hyderabad, India · Headquarters2Global headquarters (Nacharam); the Hyderabad sites are listed for small-molecule R&D and manufacturing
- Bengaluru, India · Manufacturing site2Biologics process development and GMP drug substance manufacturing (Jigani); single-use, 2.50 KL installed capacity
- Morgan Hill, United States · Laboratory2Operated as Aragen Bioscience: biologics R&D, cell line development and non-GMP small-scale manufacturing
Quality and regulatory
Quality and regulatory
The provider’s own materials state that it works to, or holds, the following. ArgusBio has not inspected or audited these claims.
- GMP / cGMP3Stated for biologics clinical drug substance manufacturing
Unknowns and questions to ask
Unknowns and questions to ask
Public sources rarely establish what matters most for a specific project. Confirm directly:
- Available capacity, slot timing and scale for your next campaign
- Recent experience with your specific modality and expression system or chemistry
- Regulatory inspection history of the specific site that would manufacture your product
- Technology-transfer approach, timeline and who owns the resulting process knowledge
- Analytical and QC release testing done in-house versus subcontracted
- Quality agreement terms, batch-failure responsibility and change-order mechanics
Not established from reviewed sources: development stage.
Evidence and sources
Evidence and sources
- 1Biologics GMP Manufacturing | Single-Use Bioreactors | Aragen (opens in a new tab)Aragen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 2CRDMO Services | Contract R&D Manufacturing Solutions - Aragen Life Sciences (opens in a new tab)Aragen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 3Large Molecule Biologics & Manufacturing Solutions - Aragen Life Sciences (opens in a new tab)Aragen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 4Large Molecule Drug Development Research - Aragen Life Sciences (opens in a new tab)Aragen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 5Cell Line Development Services - Aragen Life Sciences (opens in a new tab)Aragen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.
Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.
Contact
Contact
Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.
ArgusBio sourcing
Need help evaluating this provider or comparing alternatives.
Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.
Discuss a sourcing needWe work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.